Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2011
The primary objective of this study is to evaluate the efficacy and safety of CDP6038 administered subcutaneous (sc) at various doses compared to placebo.
Epistemonikos ID: 75efff365622786f47a8aaa636fce8e3b29dcf88
First added on: Mar 23, 2022